-
Health Canada Official Methods for the Testing of Tobacco Products (toxicity testing)
The Tobacco Reporting Regulations madeunder the Tobacco and Vaping Products Act incorporate by reference a number of Health Canada official methods that must be followed when... -
Infographic: What is fine particulate matter (PM2.5)?
Fine Particulate Matter (also known as PM2.5) are particles in the air that measure less than 2.5 micrometers (μm) in diameter, and typically consists of a mix of things like... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
The maximum acceptable concentration (MAC) for carbofuran in drinking water is 0.09 mg/L (90 µg/L). -
Novel Food Information - Soybean Producing Aryloxyalkanoate dioxygenase-12...
Health Canada has notified Dow Agrosciences Canada, Inc. that it has no objection to the food use of herbicide tolerant soybean event DAS68416-4. The Department conducted a... -
Summary Safety Review - Over-the-counter topical acne products containing...
A safety review was carried out to evaluate a potential link between serious allergic reactions (hypersensitivity reactions) and over-the-counter acne products containing either... -
Compliance Verification Project 2021-2022: Charcoal Regulations
The purpose of this Compliance Verification (CV) project was to verify industry's compliance of charcoal products to the requirements of the Charcoal Regulations. -
Bisphenol A (BPA) in Canadians
Information on human biomonitoring of BPA in Canada with results from the Canadian Health Measures Survey. -
The Cannabis Act and Cannabis Regulations - Promotion prohibitions
Prohibitions included in this document pertaining to Part 6.1 of the Cannabis Regulations came into effect on October 17, 2019. Other prohibitions referenced came into force on... -
Interim update on medical assistance in dying in Canada June 17 to December 31, 2016
On June 17, 2016, An Act to amend the Criminal Code and to make related amendments to other Acts (medical assistance in dying), which permits the lawful provision of medical... -
Frequently Asked Questions - Natural Health Products Regulations
Frequently Asked Questions - Natural Health Products Regulations. This document is an unofficial summary of the Regulations. -
Drinking water screening value for diazinon
A drinking water screening value of 0.015 mg/L (15 ug/L) is established for diazinon. -
Good Clinical Practices
These inspection and investigation functions have as main objective to reduce risks to subjects enrolled in clinical trials, while encouraging sponsors in their research... -
Notice: Preparation of Clinical Trial Regulatory Activities in the "Non-eCTD...
This Notice serves as a revision to the Release of Electronic Specifications for Clinical Trial Applications and Amendments filed in accordance with Guidance Document for... -
Summary Safety Review - DICLECTIN (doxylamine and pyridoxine combination) -...
Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of Diclectin was recently reviewed by Health Canada as... -
Consumer Information - Decorative Refillable Outdoor Torches
Decorative refillable garden torches are subject to the safety standards of the Consumer Chemicals and Containers Regulations, 2001 ( CCCR, 2001) under the authority of the... -
Label Process Series LPS2011-03, Designing Marketplace Labels of Domestic...
The purpose of this document is to provide guidance to industry and other interested parties on the development of pest control product labels for the Canadian marketplace. It... -
Hazardous Substance Assessment - Acetone
Hazardous Substance Assessments are prepared by Health Canada as educational and information resources. -
Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-15, Trifludimoxazin, Vulcarus and Voraxor... -
Drug shortages in Canada: Information for health care providers
A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The role of health care providers in addressing... -
Consumer Product Safety Program Annual Surveillance Report: 2020
This report describes the surveillance findings gathered by the Consumer Product Safety Program (CPSP) within Health Canada. The CPSP is responsible for the administration and...